bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

bisoprolol has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bax, JJ; Boersma, E; Kertai, MD; Klein, J; Lameris, TW; Poldermans, D; Schouten, O; Simoons, ML; van de Ven, LL; van Urk, H; Vermeulen, M; Visser, L1
Bax, JJ; Boersma, E; Dunkelgrun, M; Koopman-van Gemert, AW; Poldermans, D; Schouten, O; Thomson, IR; van Poorten, F1
Furuichi, Y; Sakamoto, A1

Reviews

2 review(s) available for bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Annals of surgery, 2009, Volume: 249, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Arrest; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Factors; Treatment Outcome

2009
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
    Masui. The Japanese journal of anesthesiology, 2014, Volume: 63, Issue:3

    Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Intraoperative Complications; Metoprolol; Monitoring, Intraoperative; Morpholines; Myocardial Infarction; Myocardial Ischemia; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Urea

2014

Trials

1 trial(s) available for bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).
    Annals of surgery, 2009, Volume: 249, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cohort Studies; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Arrest; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Factors; Treatment Outcome

2009

Other Studies

1 other study(ies) available for bisoprolol and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study.
    American heart journal, 2004, Volume: 148, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiovascular Diseases; Drug Therapy, Combination; Elective Surgical Procedures; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Intraoperative Complications; Myocardial Infarction; Perioperative Care; Postoperative Complications; Premedication; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Risk Assessment

2004